Mutations within the CYP2D6 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). These results were recently published in the Journal of the National Cancer Institute....
Read More...
[Source: Breast Cancer News]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment